UnitedHealth Group (NYSE:UNH) Lowered to “Hold” at StockNews.com

StockNews.com downgraded shares of UnitedHealth Group (NYSE:UNHFree Report) from a buy rating to a hold rating in a report issued on Thursday morning.

Several other equities analysts have also recently issued reports on the company. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $596.00 to $555.00 and set an outperform rating for the company in a report on Wednesday, April 17th. Morgan Stanley decreased their price objective on UnitedHealth Group from $618.00 to $584.00 and set an overweight rating on the stock in a research note on Friday, April 5th. Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $545.00 to $562.00 and gave the company a buy rating in a report on Friday, April 19th. TD Cowen cut their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a buy rating for the company in a research report on Wednesday, April 10th. Finally, Erste Group Bank reiterated a hold rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of Moderate Buy and a consensus target price of $579.74.

Read Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Stock Performance

NYSE UNH opened at $482.59 on Thursday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group has a 12-month low of $436.38 and a 12-month high of $554.70. The stock has a market capitalization of $444.17 billion, a price-to-earnings ratio of 29.50, a PEG ratio of 1.41 and a beta of 0.58. The business’s 50 day moving average is $497.01 and its two-hundred day moving average is $503.94.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the prior year, the company posted $6.26 EPS. Research analysts expect that UnitedHealth Group will post 27.57 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th will be given a $2.10 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend is Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.74%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Texas Capital Bancshares Inc TX raised its holdings in UnitedHealth Group by 1.1% in the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after acquiring an additional 19 shares in the last quarter. Tealwood Asset Management Inc. grew its stake in UnitedHealth Group by 0.4% in the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock worth $2,626,000 after purchasing an additional 19 shares in the last quarter. Atlas Private Wealth Advisors raised its stake in UnitedHealth Group by 1.1% during the fourth quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock valued at $923,000 after buying an additional 19 shares in the last quarter. Prentice Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 0.8% in the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock valued at $1,235,000 after acquiring an additional 19 shares during the last quarter. Finally, Baker Avenue Asset Management LP lifted its stake in UnitedHealth Group by 1.7% during the third quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock worth $615,000 after purchasing an additional 20 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

About UnitedHealth Group

(Get Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.